logo

For the Inventor, By the Inventor

Clinton, CT, United States of America

Yasutsugu Ueda

This inventor holds 31 USPTO granted patents and 21 published patent applications and 7 EPO patents, primarily in Antiviral Agents. Top assignees: Bristol-Myers Squibb Compnay, Bristol Meyers Squibb Company, Viiv Healthcare UK (No. 4) Limited. Active years: 1993-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasutsugu Ueda. Retrieved from https://idiyas.com/inventor/yasutsugu-ueda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.9

ph-index = 11

Forward Citations = 389(Granted Patents)


Location History:

  • Clinton, CT (US) (1993 - 2014)
  • Wallingford, CT (US) (2022)

Company Filing History:

goldMedal29 out of 3,737 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal1 out of 41 
 
Bristol Meyers Squibb Company
 patents
bronzeMedal1 out of 8 
 
Viiv Healthcare UK (No. 4) Limited
 patents

Years Active: 1993-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Antiviral Agents
HIV Integrase Inhibitors
Prodrugs
Piperazine
Azaindole
Bicyclic Heterocycles
Cephalosporin
Pharmaceutical Formulations
Diketo Compounds
Pyridines
Taxol Derivatives
31 patents (USPTO):Explore Patents
1. 11369624 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents (2022-06-28),
2. 8871771 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents (2014-10-28),
3. 8461333 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents (2013-06-11),
4. 8168615 - Prodrugs of piperazine and substituted piperidine antiviral agents (2012-05-01),
5. 8129398 - HIV integrase inhibitors (2012-03-06),
6. 8124615 - Diketo substituted pyrrolo[2,3-C]pyridines (2012-02-28),
7. 8039458 - HIV integrase inhibitors (2011-10-18),
8. 7960406 - Diketo substituted pyrrolo[2,3-c] pyridines (2011-06-14),
9. 7902182 - HIV integrase inhibitors (2011-03-08),
10. 7893055 - HIV integrase inhibitors (2011-02-22),
11. 7745625 - Prodrugs of piperazine and substituted piperidine antiviral agents (2010-06-29),
12. 7662823 - Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives (2010-02-16),
13. 7511037 - N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor (2009-03-31),
14. 7501420 - Composition and antiviral of substituted azaindoleoxoacetic piperazine derivatives (2009-03-10),
15. 7419969 - HIV integrase inhibitors: cyclic pyrimidinone compounds (2008-09-02),

Title: **Yasutsugu Ueda: Innovator in Antiviral Agents**

Introduction

Yasutsugu Ueda is a notable inventor based in Clinton, CT, recognized for his extensive contributions to pharmaceutical innovations, with a remarkable portfolio of 31 patents. His work focuses on developing antiviral agents, specifically aimed at combating diseases such as HIV.

Latest Patents

Among his latest inventions is the patent titled "Salts of prodrugs of piperazine and substituted piperidine antiviral agents." This invention introduces prodrug Compounds I, which can be formulated into pharmaceutical compositions for the effective treatment of HIV infection. Additionally, the invention details intermediate Compounds II that are essential in synthesizing the prodrug Compounds I, highlighting Ueda's innovative approach in enhancing antiviral therapies.

Career Highlights

Throughout his career, Ueda has made significant strides in the pharmaceutical industry, particularly while working with Bristol-Myers Squibb Company. His role in this leading biopharmaceutical firm allowed him to refine his expertise and focus on the development of innovative treatment solutions for various diseases.

Collaborations

Ueda has collaborated with esteemed colleagues including John D. Matiskella and Timothy P. Connolly. These partnerships have fostered innovative research and product development, underlining the importance of teamwork in achieving groundbreaking advancements in medicine.

Conclusion

In summary, Yasutsugu Ueda stands out as a prominent inventor whose contributions to antiviral research are noteworthy. With a robust portfolio of patents and valuable collaborations, he continues to push the boundaries of innovation in the pharmaceutical field, aiming to improve therapies for infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…